You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gun

Showing 26 - 50 of 1,398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine Trial in Japan (Placebo, Erenumab)

Completed
Has Results
  • Migraine
  • Kamogawa-shi, Chiba, Japan
  • +43 more
Oct 3, 2022

Early Gastric Cancer Trial in Korea, Republic of (Laparoscopic sentinel navigation surgery using fluorescence)

Not yet recruiting
  • Early Gastric Cancer
  • Laparoscopic sentinel navigation surgery using fluorescence
  • Busan, Gijang-gun, Korea, Republic of
  • +6 more
Jul 31, 2023

Plaque Psoriasis Trial in Japan (Apremilast)

Recruiting
  • Plaque Psoriasis
  • Nagoya-shi, Aichi, Japan
  • +22 more
Feb 1, 2023

Dermatitis, Atopic, Dermatitis, Eczema Trial in Japan (Lebrikizumab, Placebo, Topical Corticosteroid)

Active, not recruiting
  • Dermatitis, Atopic
  • +4 more
  • Ainokawa, Ichikawa-shi, Chiba, Japan
  • +36 more
Sep 19, 2022

sCLEC-2 in Stroke Study

Not yet recruiting
  • Acute Ischemic Stroke
  • Transient Ischemic Attack
    • Katori, Chiba, Japan
    • +8 more
    Oct 10, 2022

    Multiple Myeloma Trial in Japan (Talquetamab)

    Recruiting
    • Multiple Myeloma
    • Kamakura-shi, Japan
    • +5 more
    Aug 11, 2022

    Based on Patient Data From Digital Devices in Unresectable Stage

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Nagoya, Aichi, Japan
      • +26 more
      Aug 16, 2022

      NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

      Terminated
      • Carcinoma, Non-Small-Cell Lung
      • Kashiwa, Chiba, Japan
      • +3 more
      Jan 31, 2023

      Thrombotic Thrombocytopenic Purpura Trial in Japan (Caplacizumab (ALX-0081), Plasma exchange (PE), Corticosteroid treatment

      Completed
      • Thrombotic Thrombocytopenic Purpura
      • Caplacizumab (ALX-0081)
      • +3 more
      • Iruma-Gun, Japan
      • +11 more
      Jan 30, 2023

      ALS Trial in Japan (MT-1186)

      Recruiting
      • ALS
      • Chiba-shi, Chiba, Japan
      • +6 more
      Jan 15, 2023

      Stomach Tumors, Esophageal Tumors Trial in Japan (Amivantamab)

      Recruiting
      • Stomach Neoplasms
      • Esophageal Neoplasms
      • Chuo-Ku, Japan
      • +10 more
      Jan 27, 2023

      Special Drug Use-results Surveillance of Tabrecta Tablets

      Recruiting
      • Non-small Cell Lung Cancer
      • Tabrecta tablets
      • Nagoya, Aichi, Japan
      • +44 more
      Aug 1, 2022

      Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

      Completed
      Has Results
      • Unresectable Stage IIIB-IV Malignant Melanoma
      • Talimogene laherparepvec
      • Nagoya-shi, Aichi, Japan
      • +8 more
      Jan 13, 2023

      Solid Tumors Trial in Japan (Farletuzumab Ecteribulin)

      Active, not recruiting
      • Solid Tumors
      • Farletuzumab Ecteribulin
      • Matsuyama City, Ehime, Japan
      • +9 more
      Jul 21, 2022

      Adaptation of EDAQ Into Turkish, Examining The Reliability and

      Enrolling by invitation
      • Arthritis, Rheumatoid
      • Activities of Daily Living
      • Adaptation into Turkish, Examining The Reliability and Validity for People with RA
      • Ankara, Çankaya, Turkey
        Hacettepe University
      Feb 8, 2022

      Stomach Tumors Trial in Japan (AMG 337)

      Completed
      • Stomach Neoplasms
      • AMG 337
      • Kashiwa-shi, Chiba, Japan
      • +3 more
      Dec 23, 2021

      Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

      Recruiting
      • Takayasu Arteritis
      • Bunkyo-Ku, Japan
      • +28 more
      Aug 16, 2022

      Head Neck Cancer Trial in Japan (Paclitaxel)

      Completed
      Has Results
      • Head and Neck Cancer
      • Kashiwa-shi, Chiba, Japan
      • +8 more
      Feb 16, 2022

      Migraine Trial in Japan (Rimegepant, Placebo)

      Recruiting
      • Migraine
      • Matsuyama-shi, Ehime, Japan
      • +42 more
      Aug 16, 2022

      Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)

      Recruiting
      • Multiple Myeloma
      • Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
      • +7 more
      Jan 9, 2023

      Xospata in Relapsed or Refractory Acute Myeloid Leukemia With

      Recruiting
      • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
      • Gilteritinib Exposure
      • Goyang-si, Gyeonggi-do, Korea, Republic of
      • +4 more
      Aug 18, 2022

      Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)

      Recruiting
      • Ulcerative Colitis
      • Toyohashi-shi, Aichi- KEN, Japan
      • +70 more
      Jan 3, 2023

      Migraine Trial in Japan (Atogepant, Placebo for Atogepant)

      Not yet recruiting
      • Migraine
      • Ichikawa-shi, Chiba, Japan
      • +49 more
      May 8, 2023

      Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

      Recruiting
      • Breast Neoplasms
      • Nagoya, Aichi, Japan
      • +10 more
      Nov 11, 2022

      Patients Affected by Gunshot Related Injuries in Trauma in South

      Completed
      • Trauma, Multiple
      • Gun Shot Wound
      • No intervention
      • Cape Town, Western Cape, South Africa
        Groote Schuur Hospital
      Apr 27, 2021